Antispasmodic Medication for Biliary Colic
Hyoscine butylbromide (Buscopan) is the recommended first-line antispasmodic medication for biliary colic, but NSAIDs such as diclofenac are more effective and should be preferred when not contraindicated. 1, 2
First-Line Treatment Options
NSAIDs
- Diclofenac: 75mg intramuscular injection - provides faster and more effective pain relief than antispasmodics 2
Antispasmodics
- Hyoscine butylbromide (Buscopan): 20mg IV/IM 3
Treatment Algorithm
For patients without NSAID contraindications:
- Diclofenac 75mg IM as first choice
- Alternative: Ketorolac 60mg IM (similar efficacy to opioids) 4
For patients with NSAID contraindications:
- Hyoscine butylbromide 20mg IV/IM 3
For refractory pain:
Evidence Comparison
| Medication | Pain Relief | Prevention of Cholecystitis | Side Effects |
|---|---|---|---|
| Diclofenac | 91.7% at 4h | Reduces by ~70% | GI bleeding, renal effects |
| Hyoscine | 69.4% at 4h | Higher progression rate | Anticholinergic effects |
| Tenoxicam | Effective in 87.5% | May prevent progression | Similar to other NSAIDs |
Important Clinical Considerations
- Timing matters: Early administration of NSAIDs significantly reduces the risk of progression to acute cholecystitis 6, 2
- Contraindications to NSAIDs: Peptic ulcer disease, renal impairment, bleeding disorders, pregnancy
- Monitoring: Assess pain relief at 30 minutes, 1 hour, and 4 hours after administration
- Warning signs: Persistent pain despite medication, fever, or increasing inflammatory markers may indicate progression to cholecystitis
Pitfalls to Avoid
- Relying solely on antispasmodics when NSAIDs are not contraindicated
- Delaying treatment, which increases risk of progression to cholecystitis
- Overuse of opioids as first-line therapy when NSAIDs or antispasmodics may be sufficient
- Failing to reassess patients who don't respond to initial therapy
For patients with confirmed biliary colic, a single 75mg intramuscular dose of diclofenac provides superior pain relief and significantly reduces progression to acute cholecystitis compared to antispasmodic medications, making it the preferred first-line treatment when not contraindicated.